Skip to main content
Livermore
Livermore
ZHEN

IN8BIO, Inc.

INAB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001740279

No open-market purchases or sales by IN8BIO, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $5.35M in total; no superinvestor holds it.

Holders of 5% or more of INAB

Holders whose latest Schedule 13D or 13G filing reports 5% or more of IN8BIO, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of INAB
HolderLatest formStakeChangeFirst filedLatest filingFiling
Lytton Laurence W13G/A9.99%1.06M shares0.00 ppfrom 9.99%Mar 2, 20262 filingsAug 13, 2026SEC
Stonepine Capital Management, LLC13G9.90%1.01M sharesNewDec 22, 20251 filingDec 22, 2025SEC
Alyeska Investment Group, L.P.13G9.90%966.4K sharesNewFeb 17, 20261 filingFeb 17, 2026SEC
Franklin Resources Inc13G9.40%914.5K sharesNewJan 29, 20261 filingJan 29, 2026SEC
683 Capital Management, LLC13G7.86%770.4K sharesNewDec 30, 20251 filingDec 30, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

24 Schedule 13D and 13G filings on IN8BIO, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on INAB
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 13, 20262:21 PM ETLytton Laurence Wand 1 other13G/A9.99%1.06M shares0.00 ppfrom 9.99%Jun 30, 2026SEC
May 29, 20265:41 PM ETFairbairn Emilyand 2 others13D/A2.20%215.4K shares−5.30 ppfrom 7.50%Below 5%May 27, 2026SEC
Mar 2, 20262:01 PM ETLytton Laurence Wand 1 other13G9.99%984.0K sharesNewDec 22, 2025SEC
Feb 17, 20264:42 PM ETAlyeska Investment Group, L.P.and 2 others13G9.90%966.4K sharesNewDec 31, 2025SEC
Jan 29, 20263:48 PM ETFranklin Resources Incand 3 others13G9.40%914.5K sharesNewDec 31, 2025SEC
Jan 2, 20267:10 PM ETFairbairn Emilyand 2 others13D7.50%733.3K sharesNewDec 22, 2025SEC
Dec 30, 20251:56 PM ET683 Capital Management, LLCand 2 others13G7.86%770.4K sharesNewDec 22, 2025SEC
Dec 29, 20254:00 PM ETBIOS Fund II, LPand 18 others13D/A4.00%391.4K shares−5.99 ppfrom 9.99%Below 5%Dec 22, 2025SEC
Dec 22, 20255:15 PM ETStonepine Capital Management, LLCand 3 others13G9.90%1.01M sharesNewDec 19, 2025SEC
Aug 14, 20255:50 PM ETAlyeska Investment Group, L.P.and 2 others13G/A2.58%89.0K shares−7.32 ppfrom 9.90%Below 5%Jun 30, 2025SEC
Aug 13, 20254:55 PM ETTranscend Partners Opportunity Fund I LLC13G/A2.60%107.4K shares–Below 5%Jun 30, 2025SEC
Aug 13, 20254:53 PM ETHo William Tai-Wei13G/A3.70%151.2K shares−1.90 ppfrom 5.60%Below 5%Jun 30, 2025SEC
Jul 29, 20254:05 PM ETHirschman Orinand 1 other13G/A4.40%149.9K shares−4.10 ppfrom 8.50%Below 5%Jun 30, 2025SEC
May 8, 20255:53 PM ETBIOS Fund II, LPand 18 others13D/A9.99%9.12M shares–May 2, 2025SEC
Feb 14, 20254:41 PM ETHo William Tai-Wei13G/A5.60%4.10M shares–Dec 31, 2024SEC
Feb 14, 20254:29 PM ETAlyeska Investment Group, L.P.and 2 others13G9.90%7.24M sharesNewDec 31, 2024SEC
Jan 31, 20254:05 PM ETHirschman Orinand 1 other13G/A8.50%6.19M shares–Dec 31, 2024SEC
Feb 13, 2024Ho William Tai-Wei13G/AOld format–––SEC
Dec 15, 2023Hirschman Orin13GOld format–New–SEC
Dec 15, 2023Transcend Partners Opportunity Fund I LLC13G/AOld format–––SEC
Dec 15, 2023BIOS Fund II, LP13D/AOld format–––SEC
Aug 11, 2023Ho William Tai-Wei13GOld format–New–SEC
Aug 11, 2023Transcend Partners Opportunity Fund I LLC13GOld format–New–SEC
Aug 13, 2021BIOS Fund II, LP13DOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell IN8BIO, Inc. shares.

No Form 144 notices for IN8BIO, Inc. are on file.